BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38847312)

  • 21. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Nicolaides KH
    Am J Obstet Gynecol; 2018 Feb; 218(2):161-180. PubMed ID: 29157866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of short cervix between 20 and 24 weeks of gestation and vaginal progesterone for prolonging of gestation.
    Maerdan M; Shi C; Zhang X; Fan L
    J Matern Fetal Neonatal Med; 2017 Jul; 30(14):1646-1649. PubMed ID: 27600865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis.
    Schuit E; Stock S; Rode L; Rouse DJ; Lim AC; Norman JE; Nassar AH; Serra V; Combs CA; Vayssiere C; Aboulghar MM; Wood S; Çetingöz E; Briery CM; Fonseca EB; Worda K; Tabor A; Thom EA; Caritis SN; Awwad J; Usta IM; Perales A; Meseguer J; Maurel K; Garite T; Aboulghar MA; Amin YM; Ross S; Cam C; Karateke A; Morrison JC; Magann EF; Nicolaides KH; Zuithoff NP; Groenwold RH; Moons KG; Kwee A; Mol BW;
    BJOG; 2015 Jan; 122(1):27-37. PubMed ID: 25145491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaginal progesterone to reduce the rate of preterm birth and neonatal morbidity: a solution at last.
    Romero R
    Womens Health (Lond); 2011 Sep; 7(5):501-4. PubMed ID: 21879816
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaginal Progesterone to Prevent Spontaneous Preterm Birth in Women With a Sonographic Short Cervix: The Story of the PREGNANT Trial.
    Romero R; Meyyazhagan A; Hassan SS; Creasy GW; Conde-Agudelo A
    Clin Obstet Gynecol; 2024 Jun; 67(2):433-457. PubMed ID: 38576410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in twin gestations: a systematic review and meta-analysis.
    Conde-Agudelo A; Romero R; Rehal A; Brizot ML; Serra V; Da Fonseca E; Cetingoz E; Syngelaki A; Perales A; Hassan SS; Nicolaides KH
    Am J Obstet Gynecol; 2023 Dec; 229(6):599-616.e3. PubMed ID: 37196896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaginal progesterone in women with twin gestations complicated by short cervix: a retrospective cohort study.
    Brubaker SG; Pessel C; Zork N; Gyamfi-Bannerman C; Ananth CV
    BJOG; 2015 Apr; 122(5):712-8. PubMed ID: 25428801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention of preterm birth with vaginal progesterone in women with preterm labor: which are the evidences?].
    Martinez de Tejada B; Othenin-Girard V; Irion O
    Rev Med Suisse; 2015 Oct; 11(492):2004, 2006-8, 2010. PubMed ID: 26672179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety.
    El-Refaie W; Abdelhafez MS; Badawy A
    Arch Gynecol Obstet; 2016 Jan; 293(1):61-67. PubMed ID: 26044148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early universal use of oral progesterone for prevention of preterm births in singleton pregnancy (SINPRO study): protocol of a multicenter, randomized, double-blind, placebo-controlled trial.
    Cheung KW; Seto MTY; Ng EHY
    Trials; 2020 Jan; 21(1):121. PubMed ID: 32000820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled trial on the use of pessary plus progesterone to prevent preterm birth in women with short cervical length (P5 trial).
    Pacagnella RC; Mol BW; Borovac-Pinheiro A; Passini R; Nomura ML; Andrade KC; Ellovitch N; Fernandes KG; Bortoletto TG; Pereira CM; Miele MJ; França MS; Cecatti JG;
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):442. PubMed ID: 31775669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervical pessary versus vaginal progesterone in women with a singleton pregnancy, a short cervix, and no history of spontaneous preterm birth at less than 34 weeks' gestation: open label, multicentre, randomised, controlled trial.
    van Dijk CE; van Gils AL; van Zijl MD; Koullali B; van der Weide MC; van den Akker ES; Hermsen BJ; van Baal WM; Visser H; van Drongelen J; Vollebregt KC; Muller M; van der Made FW; Gordijn SJ; de Mooij YM; Oudijk MA; de Boer MA; Mol BW; Kazemier BM; Pajkrt E;
    BMJ; 2024 Mar; 384():e077033. PubMed ID: 38471724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical pessary plus vaginal progesterone versus long-term tocolysis for the prevention of preterm birth: An observational retrospective study.
    Tajima M; Yanazume S; Orita Y; Tazaki Y; Shinya M; Kobayashi H
    Int J Gynaecol Obstet; 2020 Aug; 150(2):206-212. PubMed ID: 32282943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Very short cervix in low-risk asymptomatic singleton pregnancies: Outcome according to treatment and cervical length at diagnosis.
    Souka AP; Papamihail M; Pilalis A
    Acta Obstet Gynecol Scand; 2020 Nov; 99(11):1469-1475. PubMed ID: 32333390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short cervical length dilemma.
    Suhag A; Berghella V
    Obstet Gynecol Clin North Am; 2015 Jun; 42(2):241-54. PubMed ID: 26002164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM; Lewis DF
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous Preterm Birth in Multiples.
    Biggio JR; Anderson S
    Clin Obstet Gynecol; 2015 Sep; 58(3):654-67. PubMed ID: 26083129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaginal progesterone combined with cervical pessary: A chance for pregnancies at risk for preterm birth?
    Stricker N; Timmesfeld N; Kyvernitakis I; Goerges J; Arabin B
    Am J Obstet Gynecol; 2016 Jun; 214(6):739.e1-739.e10. PubMed ID: 26692180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical pessary vs vaginal progesterone for prevention of preterm birth in women with twin pregnancy and short cervix: economic analysis following randomized controlled trial.
    Le KD; Nguyen LK; Nguyen LTM; Mol BWJ; Dang VQ
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):339-347. PubMed ID: 31432562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventing preterm birth with progesterone: costs and effects of screening low risk women with a singleton pregnancy for short cervical length, the Triple P study.
    van Os MA; van der Ven JA; Kleinrouweler CE; Pajkrt E; de Miranda E; van Wassenaer A; Porath M; Bossuyt PM; Bloemenkamp KW; Willekes C; Woiski M; Oudijk MA; Bilardo KM; Sikkema MJ; Duvekot JJ; Veersema D; Laudy J; Kuiper P; de Groot CJ; Mol BW; Haak MC
    BMC Pregnancy Childbirth; 2011 Oct; 11():77. PubMed ID: 22023876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.